JORDAN HOUSTON: Open Payments
NPI 1013446103 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,799 in 65 payments from 16 companies in 2025. Trend: 2023 $1,286 · 2024 $2,945 · 2025 $4,799
Speaker / faculty: $3,400Food & beverage: $1,240Travel & lodging: $159
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $3,921 |
| Ardelyx, Inc. | 10 | $169 |
| Madrigal Pharmaceuticals | 5 | $94 |
| Ipsen Biopharmaceuticals, Inc | 4 | $74 |
| Gilead Sciences, Inc. | 4 | $73 |
| QOL Medical, LLC | 2 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| GENZYME CORPORATION | 2 | $63 |
| Janssen Biotech, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
Products named: LINZESS, IBSRELA, REZDIFFRA, DUPIXENT, RINVOQ, IQIRVO, Sucraid, TREMFYA.
Industry payments across GA — which companies pay providers there.
